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Abstract
We have established a novel in vitro co-culture system of human brain endothelial cells (HBEC), Plasmodium falciparum
parasitised red blood cells (iRBC) and peripheral blood mononuclear cells (PBMC), in order to simulate the chief
pathophysiological lesion in cerebral malaria (CM). This approach has revealed a previously unsuspected pro-inflammatory
role of the endothelial cell through potentiating the production of interferon (IFN)-c by PBMC and concurrent reduction of
interleukin (IL)-10. The IFN-c increased the expression of CXCL10 and intercellular adhesion molecule (ICAM)-1, both of
which have been shown to be crucial in the pathogenesis of CM. There was a shift in the ratio of IL-10:IFN-c protein from.1
to ,1 in the presence of HBEC, associated with the pro-inflammatory process in this model. For this to occur, a direct
contact between PBMC and HBEC, but not PBMC and iRBC, was necessary. These results support HBEC playing an active role
in the pathogenesis of CM. Thus, if these findings reflect the pathogenesis of CM, inhibition of HBEC and PBMC interactions
might reduce the occurrence, or improve the prognosis, of the condition.
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Introduction
Malaria continues to be one of the most significant infectious
diseases in the world, assailing developing countries in terms of
both morbidity and mortality. Cerebral malaria (CM) is the most
severe manifestation of Plasmodium falciparum malaria infection with
an average mortality rate of around 20% even when treated with
anti-malarial drugs [1,2]. Despite decades of study, a detailed
understanding of the causative mechanisms in CM has so far not
been achieved. Studies of CM can be categorised into four broad
types [3]: clinical or genetic studies undertaken in malaria endemic
areas, in vivo experiments utilising animal models, histopathological
studies on post-mortem materials and in vitro investigations of the
interactions between the cell types that contribute to the disease.
Clinical studies have often involved measuring cytokines or
other biomarkers in the serum/plasma [4,5,6] and cerebrospinal
fluid (CSF) from malaria patients [7]. They also include the study
of post-mortem material (brains) from patients who succumbed to
the disease. Another aspect of clinical work is investigation of the
neurological sequelae in survivors of CM. Experimental in vivo
studies, on the other hand, involve the use of animal models to
study CM. Even though differences between human and murine
CM have been described [8,9], the animal model has proven to be
versatile and revealing, in particular with gene ablation studies,
where inferences can be made by comparing gene knockout mice
to wild type mice in their response towards the disease. An
important finding originating from this approach is that the pro-
inflammatory cytokine interferon-c (IFN-c) is crucial for the
pathogenesis of experimental CM [10,11,12].
In vitro cultures also have been performed, utilising selected cells
observed in the CM lesion, such as brain endothelial cells,
peripheral blood mononuclear cells, platelets and parasitised red
blood cells [13]. This allows the study of interactions between
different cell types. These studies largely have been limited to
bipartite cultures, which do not fully represent the cellular
components of the CM lesion. Some studies that have used
human brain endothelial cells, platelets and iRBCs in vitro have
revealed roles for platelets in the pathogenesis of CM in tripartite
cultures [14,15,16,17,18]. However, PBMCs have yet to be
included in a tripartite culture system to model the lesion in CM.
Hence, for this study, we established a novel tripartite culture,
using human PBMCs, iRBCs and HBEC, in order to simulate the
vascular lesion of CM. We hypothesised that PBMCs, along with
HBEC, would interact with the iRBCs, leading to up-regulation of
the expression of inflammatory genes.
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Results
1. Endothelial cells (HBEC-5i) enhance IFN-c production,
but decrease that of IL-10, in PBMC/ 3D7 iRBC co-cultures
In nine separate experiments with the novel tripartite cultures of
HBEC, PBMCs (from donor N) and iRBC (strain 3D7), IFN-c
mRNA expression was significantly enhanced when endothelial
cells were present (PBMC N + 3D7 + HBEC, Figure 1A). IFN-c
protein expression echoed that of mRNA, with a 6.8-fold
enhancement in cultures with HBEC-5i compared to PBMC +
iRBC without endothelial cells (Figure 1A). This effect was
parasite-dependent, since significant increases of IFN-c mRNA
and protein were not observed in the corresponding controls of
HBEC + PBMC, PBMC only, HBEC + PBMC + uRBC (uRBC =
uninfected red blood cells) and PBMC + uRBC. The results
suggest that HBEC amplified the induction of IFN-c expression by
PBMC in this co-culture arrangement.
The expression of an anti-inflammatory cytokine, IL-10, in the
tripartite culture system was reduced. Production of this cytokine,
in terms of protein (Figure 1A), but not mRNA, was dependent on
the presence of parasitised red blood cells. Both IL-10 mRNA and
protein, however, were significantly suppressed in the presence of
endothelial cells, again implying that HBEC exert an overall pro-
inflammatory effect in this system.
Expression of the cytokine TNF, like IL-10, was significantly
reduced in the presence of HBEC (Figure 1B). This was
unexpected, given that TNF expression can be regulated by
IFN-c.
2. Heterogeneity between PBMC donors, but not parasite
strains, in IFNc production in co-culture
Following the assessment of the cytokine responses of the initial
donor PBMC (designated ‘‘PBMC N’’), two further PBMC donors
(designated PBMC L and O) were tested for their capacity to
induce IFN-c in the tripartite cultures. Heterogeneity in the IFN-c
response between donors in bipartite incubations of PBMC and
iRBC has been reported by others [19,20,21,22]. PBMC L and O
were selected from among 6 donors for their low, or lack of,
reactivity towards 3D7 iRBC in a preliminary experiment in terms
of IFN-c mRNA (data not shown). As hypothesised, heterogeneity
in the IFN-c response was seen, with PBMC L and PBMC O
showing initial lower induction of IFN-c mRNA in the tripartite
culture compared to PBMC N. In contrast, there was no difference
in the pattern of IL-10 mRNA expression between the three
donors (Figure 2A).
Different laboratory maintained strains of P. falciparum (3D7,
CS2, 3Ci and E8B) were then tested for their ability to elicit IFN-c
and IL-10 production in the tripartite culture system. No
heterogeneity between the strains was observed in the context of
the tripartite culture (Figures 2B and 2C), as the patterns of
expression of IFN-c and IL-10 mRNA were similar to those in
Figure 1A.
3. ICAM-1 and CXCL10 expression is IFN-c dependent
To demonstrate the functional capacity of the IFN-c produced
by the tripartite culture, the expression of two of its downstream
effectors, ICAM-1 and CXCL10, was studied. Both of these are
considered to be important in the pathogenesis of CM. ICAM-1 is
acting as a major adhesion molecule for iRBC [23,24] as well as
leukocytes, possibly via LFA-1 [25,26]. CXCL10 functions as a
chemokine and deletion of its receptor, CXCR3, is protective in
experimental cerebral malaria [27]. We employed an antibody
that neutralises IFN-c in order to determine whether production of
these downstream effectors was regulated by IFN-c in the tripartite
culture.
As predicted, ICAM-1 mRNA induction was enhanced in the
tripartite arrangement. This mRNA expression was reduced by
70% following the addition of IFN-c neutralising antibody
(Figure 3A), suggesting that the ICAM-1 induction is IFN-c
dependent. CXCL10 expression in PBMC induced by 3D7 iRBCs
was potentiated in the presence of HBEC, with 500- and 91-fold
increases of mRNA and protein respectively compared to
observations in the absence of endothelial cells (Figure 3B). The
addition of IFN-c neutralising antibody abrogated CXCL10
expression. In contrast, addition of isotype-matched control
antibodies did not affect ICAM-1 or CXCL10 production
(Figure 3A, B).
4. IL-10:pro-inflammatory cytokine ratios are decreased in
the presence of HBEC
It has been suggested that a reliable predictor of malaria severity
is comparison of the ratio between TNF and IL-10 protein levels
in the plasma [28,29]. A ratio of IL-10:TNF of less than 1
correlated with severe malaria whereas a ratio of more than 1 was
associated with uncomplicated malaria [29]. In our study, in the
culture supernates with HBEC, we observed significant decreases,
from .1 to ,1, in the ratio of IL-10:TNF as well as IL-10:IFN-c
proteins (Figure 4). In addition, although the ratio in the absence
of HBEC is already lower than 1, we found a similar significant
reduction of the IL-10: CXCL10 ratio when HBEC were added
into the system.
5. IFN-c enhancement is caspase-1 independent
To study the upstream events leading to the expression of IFN-c
in this co-culture system, the potential involvement of cytokines
such as IL-1b, IL-12 and IL-18 was explored. All these cytokines
provide co-stimulatory signals that elicit the expression of IFN-c
from immune cells, including NK cells [30]. To determine
whether IL-18 and IL-1b are crucial for IFN-c expression in this
tripartite culture model, YVAD, an inhibitor of caspase-1, was
used to inhibit caspase-1-mediated activation of pro-IL-1b and
pro-IL-18 to their active forms [31]. YVAD did not affect IFN-c
protein level in the tripartite cultures (PBMC + HBEC + iRBC
+YVAD) (Figure 5) when compared to its DMSO control (PBMC
+ HBEC + iRBC + DMSO). In addition to IFN-c, IL-1b
production was analysed to verify the activity of YVAD in this
system. Addition of YVAD did indeed reduce the level of IL-1b in
culture supernates (Figure 5). These results imply that IFN-c
production is independent of caspase-1 activity and, hence, IL-18
in this co-culture system. We were not able to quantify IL-18, due
to technical limitations of the FlowCytomix multiple analyte
detection system employed. IL-12 on the other hand, was
undetectable in the supernates in our model, and hence was not
pursued further (data not shown).
6. Enhancement of IFN-c production by HBEC is contact
dependent
As we did not find evidence for IFN-c expression being cytokine
mediated, we examined the contact dependency between the
different cell types in the induction of IFN-c in the tripartite
culture, using transwell inserts (pore size of 0.4 mm). HBEC were
always situated in the lower chamber. Preventing physical contact
of PBMCs with other cellular components, by isolating them in the
upper chamber, reduced the amount of IFN-c mRNA by 70%,
compared to control (p,0.001, Fig. 6A). This was also observed
when both iRBCs and PBMCs were separated in the upper
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chamber (Figure 6A). The separation of the iRBCs in the upper
chamber, and co-culture of PBMC and HBEC in the lower
chamber, did not significantly reduce IFN-c mRNA expression.
These data imply that P. falciparum stimulates IFN-c production in
the tripartite culture in a contact independent fashion, likely
through released antigens or other soluble factors. This same
pattern of expression was observed at the protein level (Figure 6A),
with one exception, as separation of the iRBC from the HBEC
and PBMC resulted in a modest but significant reduction in IFN-c
expression, by about 40% (Figure 6A). These results indicate that
PBMCs are required to be in close contact with HBEC in order to
evoke maximal amounts of IFN-c. Importantly, the data confirm
that PBMCs, rather than HBEC, are the source of IFN-c in this
system.
Similar to the effects on IFN-c, isolation of PBMC from the
other culture components considerably reduced both CXCL10
and ICAM-1 levels. If the upper chamber contained either PBMC
alone, or PBMC and iRBC together, the amount of
CXCL10 mRNA and protein was reduced (Figure 6B), suggesting
that contact between PBMC and HBEC is essential to generate
the maximal amounts of CXCL10 in the presence of iRBCs.
These data also suggest that the source of CXCL10 mRNA may
be both PBMC and HBEC, as both cell types expressed similar
levels even when separated (Figure 6B). In parallel to the patterns
of expression seen with CXCL10, ICAM-1 mRNA was signifi-
cantly diminished by 70% when PBMC were separated in the
upper chamber compared to when all components were cultured
together in the lower chamber (Figure 6C). Again, isolation of
iRBCs in the upper chamber had no effect on ICAM-1 mRNA
Figure 1. Effect of endothelial cells on cytokine production in PBMC/iRBC co-cultures. A. Significant alterations in IFN-c and IL-10 (mRNA
and protein) production in PBMC/iRBC (P. falciparum strain 3D7) co-culture in the presence of endothelial cells (HBEC-5i). B. TNF protein production
was significantly decreased in the presence of HBEC-5i. uRBC= unparasitised red blood cells. Control = no PBMC, uRBC or iRBC. Columns and
horizontal bars represent means 6 SEM of nine experiments. Two-way ANOVA showed significant differences among the groups (*p,0.05;
***p,0.001), identified using the Bonferroni post hoc test.
doi:10.1371/journal.pone.0069521.g001
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Figure 2. Influence of PBMC origin and malaria parasite strain on cytokine production in tripartite cultures. A. Differences in the
pattern of IFN-c, but not IL-10, mRNA production between donor PBMCs (L, N and O) in tripartite culture. B: No difference in the pattern of IFN-c
expression in response to P. falciparum strains 3D7, CS2, 3Ci and E8B in the tripartite culture. C: Similar pattern of IL-10 expression with several P.
falciparum strains in the tripartite culture. uRBC = unparasitised red blood cells. Control = no PBMC, uRBC or iRBC. Columns and horizontal bars
represent means 6 SEM of three to nine experiments. Two-way ANOVA showed significant differences among the groups (*p,0.05; **p,0.01;
***p,0.001), using the Bonferroni post hoc test.
doi:10.1371/journal.pone.0069521.g002
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production. Culture of both iRBCs and PBMCs together in the
upper chamber also resulted in an apparent, but not significant,
reduction of ICAM-1 mRNA. Finally, the induction of ICAM-
1 mRNA was shown to be occurring mainly in HBEC, rather than
PBMCs, as demonstrated in Figure 6C when HBEC were
separated from PBMCs by the transwell inserts. Overall, these
data support a model where HBEC and PBMCs require close
contact in order to potentiate IFN-c, and subsequently CXCL10
and ICAM-1, expression.
7. IFN-c enhancement is substantially dependent on NK
cells
To narrow down the possible ligands and receptors responsible
for the phenomenon of endothelial cell enhancement of IFN-c
production, we used a cell-sorting approach to deplete selected
subsets in the PBMC stabilates prior to our standard co-culture
experiments. As the literature has described a range of cellular
sources (T, NK, NKT and cd T cells) as being responsible for IFN-
c production in the response of PBMC to parasitised red blood
cells in bipartite cultures [32,33,34], an ideal approach would have
involved depletion of all subsets in turn. However, due to limited
stocks of the relevant PBMC, we focused on NK cells, as these
have been the most widely-reported source. Using the NK specific
Figure 3. HBEC-dependent induction of ICAM-1 and CXCL10 in tripartite co-cultures is inhibited by IFN-c neutralising antibody. A.
IFN-c neutralising antibody inhibits ICAM-1 mRNA induction in tripartite cultures. B. IFN-c neutralising antibody inhibits expression of CXCL10 mRNA
and protein in the tripartite cultures. uRBC = unparasitised red blood cells. Control = no PBMC, uRBC or iRBC. Columns and horizontal bars represent
means 6 SEM of three experiments. Two-way ANOVA showed that the values contained significant differences among the groups (***p,0.001),
using ANOVA and the Bonferroni post hoc test.
doi:10.1371/journal.pone.0069521.g003
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markers CD16+, CD56+ and NKp46+, and the gating strategy
shown in Figure 7A, PBMC were depleted of NK cells (.99%
purity) and subsequently cultured with iRBC and HBEC. In two
independent experiments, IFN-c protein production was greatly
reduced in NK-depleted PBMC cultures compared to the
corresponding co-culture from which NK cells were not depleted,
PBMC N + 3D7 + HBEC (Figure 7B). These data indicate that
NK cells were involved in the production of IFN-c in the tripartite
culture.
8. IFN-c production is co-stimulated by human brain
endothelial cells, potentially via MHCII, ICOSL, IL-2 and
B7-1/B7-2
Having shown that NK cells were partly responsible for the
increase of IFN-c protein in the tripartite culture, we next
explored the possible involvement of several molecules in this
system. Those studied were the major histocompatibility complex
II (MHC II), Inducible costimulator molecule ligand (ICOSL),
interleukin-2 (IL-2) and B7-1/B7-2. The first three were tested by
the addition to co-cultures of neutralising antibodies. B7-1/B7-2
actions were blocked with Orencia (Abatacept), a fusion protein of
the Fc region of IgG1 and the extracellular domain of CTLA-4.
Pooled data from two independent experiments showed that
MHCII, ICOSL, IL-2 and B7-1/B7-2 inhibition individually did
not affect IFNc expression in tripartite cultures, compared to their
respective isotype controls (Figure 8A-D). However, when
administered together, the treatments decreased IFN-c expression
to almost control levels in two separate experiments (Figure 8E),
suggesting that two or more of the four molecules may act in
concert to stimulate IFN-c expression.
Discussion
The mechanisms leading to the pathology seen in CM are still
the topic of considerable debate. This study presents, for the first
time, a novel tripartite culture system consisting of three major cell
types involved in the lesion of CM: brain endothelial cells, iRBC
and PBMC. We wished to determine whether endothelial cells
would modulate the production of immune mediators by PBMC
stimulated by iRBC. This might throw light on the interactions of
these three cell types at a critical location, the brain microvascu-
lature. The primary focus in this model was on the local expression
Figure 4. Ratio of IL-10:IFN-c, IL-10:TNF and IL-10:CXCL10
protein in the presence and absence of HBEC. Columns and
vertical bars represent means 6 SEM of three experiments. Statistical
significance (***p,0.001) was assessed using ANOVA and the
Bonferroni post hoc test.
doi:10.1371/journal.pone.0069521.g004
Figure 5. Effect of caspase-1 inhibition on IFN-c and IL-1b production in co-cultures of PBMC and iRBC. YVAD did not affect IFN-c
production but did inhibit that of IL-1b. uRBC=unparasitised red blood cells. Control = no PBMC, uRBC or iRBC. YVAD (50 mmol/L), a caspase-1
inhibitor, was pre-incubated with PBMC and HBEC for 30 min prior to addition of the iRBCs. At 24 h, supernates were analysed for IFN-c and IL-1b.
Columns represent values from a single experiment.
doi:10.1371/journal.pone.0069521.g005
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of IFN-c, a pro-inflammatory cytokine that is generally accepted
to be crucial in driving the pathogenesis of CM [13,35,36,37] as
well as being central to anti-malarial immunity [38]. Clinical
studies have described a correlation between IFN-c levels and the
occurrence of CM in humans [39,40,41]. Based on animal studies,
this IFN-c appears to derive from immune cells that have
accumulated within the brain vasculature prior to the terminal
phases of pathology. Previously, innate production of IFN-c by
PBMCs in response to iRBC has been reported by a number of
groups, although this has been limited to bipartite cultures
consisting of PBMC and iRBC. More importantly, design and
interpretation of these studies has focused primarily on under-
standing the cellular and molecular pathways involved in IFN-c
production, rather than any effects on pathology. Taken together
these studies suggest that production of IFN-c by leukocytes
sequestered within brain microvessels, and therefore in close
contact with endothelial cells, is important for CM pathology.
Since suitable human experimental systems for investigating the
role of IFN-c in the pathogenesis of CM are not available, such
investigations are limited to animal models. In animal studies using
P. berghei ANKA, IFN-c has been shown to be critical for the
development of experimental CM (ECM). Neutralisation of IFN-c
in mice infected with P. berghei ANKA protects against the
manifestation of ECM [42], and mice that are deficient in IFN-c
were also resistant to ECM [12,43,44]. The mechanisms by which
IFN-c drives pathology in this model are likely to be multiple.
Firstly, tissue sequestration of parasites, including to the brain, is
mediated by IFN-c [45]. More relevant to the current study, IFN-
Figure 6. Effect on immunomodulator expression of the physical separation of cellular components of the tripartite system. The
enhancement of IFN-c (A), CXCL10 (B) and ICAM-1 (C) production was perturbed when PBMC were physically separated from HBEC. iRBCs, iRBCs +
PBMCs or PBMCs were isolated in the upper chamber of the transwell insert, whereas HBEC were consistently retained in the bottom chamber.
Columns and horizontal bars represent means 6 SEM of three experiments. One way ANOVA showed significant differences among the groups
(*p,0.05; **p,0.01; ***p,0.001), using Tukey’s post hoc test.
doi:10.1371/journal.pone.0069521.g006
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c-induced chemokines, in particular CXCL10, are crucial for the
migration of leukocytes to the brain [11,27].
Here, in the tripartite culture model, our results showed a novel
role of endothelial cells in potentiating IFN-c production by
PBMC in response to iRBC, and subsequent IFNc-dependent
processes that have been implicated in CM. It should be noted that
we studied only a 24 hour co-incubation period, and it is possible
that the results would have been different at other time points. An
important finding of our co-culture system is that expression of
both CXCL10 and ICAM-1 mRNA was enhanced in the
presence of endothelial cells in an IFN-c- and contact-dependent
manner. CXCL10, also known as IP-10 (Interferon gamma
Figure 7. Effect of NK depletion on IFN-c production in tripartite cultures. A. NK cell depletion strategy. B. IFN-c protein production was
decreased by NK cell depletion. uRBC = unparasitised red blood cells. Control = no PBMC, uRBC or iRBC. ‘‘PBMC N (NK depleted)’’ co-cultures
contained PBMC that had been depleted of 99% NK cells stained with CD16, CD56 and NKp46 prior. ‘‘PBMC N’’ refers to co-cultures in which PBMC
had not been depleted of NK cells. Co-cultures were 24 h, following which supernates were harvested and analysed for IFNc. Columns represent
means of two separate experiments.
doi:10.1371/journal.pone.0069521.g007
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Figure 8. Effects of MHC II, ICOSL, IL-2 neutralisation on IFN-c production in the tripartite cultures. Individually, anti-MHC II (A), anti-
ICOSL (B), anti-IL-2 (C) and Orencia (D) did not affect IFN-c production. However, when all treatments were combined they did reduce the endothelial
cell-mediated enhancement of IFN-c (E). uRBC = unparasitised red blood cells. Control = no PBMC, uRBC or iRBC. MHC II, ICOSL and IL-2 neutralising
antibodies, and Orencia, were incubated with the tripartite cultures for 24 h. Supernates were then harvested and analysed for IFN-c. Columns
represent means of two separate experiments.
doi:10.1371/journal.pone.0069521.g008
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induced protein 10), signals through CXCR3 and is a key
chemokine involved in T helper and T cytotoxic cell migration
[46,47]. The relevance of CXCL10 to the pathogenesis of CM is
highlighted by studies showing that CXCL10 is markedly
increased in the plasma of fatal CM cases as compared to other
non-CM cases [48]. Furthermore, mice deficient in CXCL10 or
CXCR3 are partially resistant to CM [11,27,49,50]. ICAM-1 is an
adhesion molecule that has been implicated in the development of
murine CM. ICAM-1 is a host receptor for the PfEMP1 molecule
of iRBCs [51], so an increase in ICAM-1 expression is likely to
lead to sequestration of iRBCs as well as the recruitment of more
PBMCs, potentially leading to CM. This was supported recently
by human studies in which ICAM-1 binding by iRBCs was
associated with CM [23]. Although TNF has been considered the
primary inducer of ICAM-1 in CM [52,53], there are also reports
that suggest that IFNc provides a stronger signal for induction of
this molecule in vitro [54,55]. Importantly, in our study neutral-
isation of IFN-c reduced expression of ICAM-1 and
CXCL10 mRNA to almost control levels (Figure 3), which further
supports a role for IFN-c in the pathogenesis of CM.
The results shown here were obtained with PBMC from a naive
donor that reacted strongly to iRBC in terms of IFN-c induction.
Such heterogeneity in IFN-c responsiveness is not surprising,
considering that only a very small fraction of P. falciparum-infected
patients develop CM. Indeed, it is well-established that PBMC
from malaria-naı¨ve donors show a very wide range of responsive-
ness to iRBC in terms of IFN-c production [41,56,57]. Further-
more, since a range of P. falciparum strains induced similar levels of
IFN-c in tripartite co-culture, it is likely that the strains used in this
study may share a common factor that is crucial for the induction
of IFN-c and that host, rather than parasite, factors may be the
dominant contributors to CM pathology.
In contrast to the clearly pro-pathogenic role of IFN-c in CM,
the influence of IL-10 and TNF on disease is unclear, but IL-10
levels in particular have been argued to be a prognostic indicator
of protection from pathology. The actual role of IL-10 is
debatable, as comparisons of plasma samples from children
afflicted with mild and severe forms of malaria showed that IL-
10 levels were significantly lower in patients with the more severe
forms of malaria [58,59], though it must be noted that another
study did not support this finding [60]. Any protective effect of IL-
10 is presumably a result of the anti-inflammatory activity of this
cytokine [61]. TNF was initially deemed important in CM [4,62],
but abrogation of the TNF gene in the murine model of CM did
not confer resistance to CM [63]. Nevertheless, the IL-10:TNF
ratio in patient plasma has been shown to correlate predictively
with severe disease [29]. In our tripartite co-culture system,
inclusion of endothelial cells lead to diminished IL-10 production,
which when coupled with the enhanced IFN-c production, led to a
dramatic inversion in the IL-10:IFN-c ratio in the presence of
HBEC. Similar, but less pronounced, changes in the IL-10:TNF
and IL-10:CXCL10 ratios were also seen in our culture system,
which again is consistent with a pro-pathogenic function of
endothelial cells.
The pro-inflammatory activity of the endothelial cells was
mediated through cell-cell contact rather than soluble mediators.
When PBMCs were separated from the tripartite cultures in
transwells (Figure 6A, 6B and 6C), IFN-c mRNA and protein, as
well as CXCL10 and ICAM mRNA levels, were reduced. Taken
together, these data indicate that in the tripartite cultures, up
regulation of IFN-c, ICAM-1 and CXCL10 induction requires
contact-dependent signals between PBMC and HBEC. Interest-
ingly, the separation of the iRBCs from other culture components
did not significantly reduce the amount of IFN-c mRNA,
suggesting that neither cytoadherence of iRBC to HBEC nor
direct effects of released merozoites are important in this
mechanism.
The source of IFN-c in P. falciparum co-culture systems has been
a matter of intense debate, with NK cells [21,22,26,57,64,65],
CD8+ T cells [34] and cd T cells/ NKT cells [33] being argued to
be the dominant source. Of the likely parasite factors involved in
immune stimulation, it has been shown that glycosylphosphatidy-
linositol [66], hemozoins [67,68,69], uric acid [70] as well as
microparticles [71] are capable of eliciting pro-inflammatory
activity such as expression of IFN-c and TNF. To determine the
source of IFN-c in our studies, we focused on NK cells as the
majority of published studies support them being the major
producers of this cytokine. NK depletion experiments (Figure 7A
and 7B) showed that NK-depleted PBMC produced lower levels of
IFN-c protein in the tripartite culture system, when compared to
NK replete PMBC cultures. Nevertheless, PBMCs that had been
depleted of NK cells still produced residual amounts of IFN-c even
in the absence of other culture components. One possible
explanation for this apparent heterogeneity of cellular source is
that IFN-c production by various cell types may be time-
dependent, with 24 hours culture (the time point used in the
present study) marking a transition from NK to CD4 T cells as the
dominant source [34].
As far as interactions between endothelial cells and NK cells are
concerned, potential co-stimulatory molecules on endothelial cells
have been extensively reviewed [72] and these include ICOSL
(inducible co-stimulator ligand) and PD-1 L (programmed death 1
ligand). On the other hand, NK cells possess a variety of receptors
such as CD28, a ligand of B7-1/B7-2 molecules [73], which is
expressed by endothelial cells as well as monocytes and dendritic
cells. Another molecule of interest is MHC II, which, apart from
being involved in antigen presentation, has also been described as
being capable of synergising with Toll-like receptors in mounting
innate immune responses [81,82]. Furthermore, higher inducibil-
ity of MHC II expression in murine brain endothelial cells is
associated with genetic susceptibility to CM in one model of ECM
[74]. Even though we did not find any significant reduction in
IFN-c protein in the tripartite cultures with single additions of
MHC II, ICOSL, IL-2 neutralising antibodies and Orencia, a B7-
1/B7-2 antagonist, when these were added together IFN-c
induction was largely abolished (Figure 8E). This evidenced the
potential of these molecules to act in concert for the induction of
IFN-c by HBEC in the presence of both iRBCs and PBMC. Our
findings so far suggest that endothelial cells provide co-stimulatory
signals in this co-culture system.
Conclusion
We describe for the first time a novel tripartite culture using
HBEC, PBMC and iRBC. In this co-culture system, HBEC
actively participate in the pro-inflammatory response by enhanc-
ing IFN-c production, which in turn leads to induction of a
chemokine (CXCL10) and a cell surface receptor (ICAM-1) that
have been implicated in CM pathology. These results indicate a
need to further investigate the role of endothelial cells in end stage
CM pathology, and suggest that therapeutic interventions that
target endothelial cell/leukocyte interactions may be possible.
Materials and Methods
Ethics statement
Human buffy coat preparations and outdated erythrocytes were
purchased from the Red Cross Blood Service, Sydney. Donors
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gave written informed consent. The studies were approved by the
University of Sydney Human Ethics Committee.
P. falciparum culture
P. falciparum cultures were maintained using methods modified
from those described by Trager and Jensen [75]. In brief, parasites
were grown in group O+ human erythrocytes in Malaria Complete
Medium (MCM) consisting of RPMI 1640 fortified with 2 mmol/
L glutamine (Thermo Fisher Scientific, USA), glucose (10 mmol/
L, Amresco, USA), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) (25 mmol/L, Research Organics, USA), sodium
bicarbonate (32 mmol/L, Research Organics, USA) and albumax
II (0.5%, w/v, Life Technologies, USA). Cultures were contained
in sealed T25 or T75 flasks (Corning, USA) at 5% hematocrit and
flushed with a gas mix of 5% O2, 5% CO2, and 90% N2 (Coregas,
Yennora, New South Wales). The P. falciparum lines used in this
study were 3D7 [76], CS2 [77], 3Ci [78] and E8B [79]. HBEC
and the parasite strains used were tested to be mycoplasma-free
throughout the experimentation by the means of a PCR detection
kit (Minerva BioLabs, Germany). For co-culture experiments,
schizonts and mature trophozoites were enriched via magnetic
separation [80] with an AutoMACSH (Miltenyi Biotec, Germany).
The studies were performed with these late stages of the cycle
because they are the predominant forms that sequester in the brain
microcirculation in CM [81]
Human brain endothelial cell culture
The human brain endothelial cell line 5i (HBEC) [16] was
cultured in 25 cm2 (T25) or 75 cm2 (T75) flasks (NUNC,
Denmark, pre-coated overnight with 0.1% gelatine (w/v in
distilled water, Sigma-Aldrich, USA) using Dulbecco’s Modified
Eagle Media: Nutrient Mixture F-12 (Thermo Fisher Scientific,
USA) enriched with 10% (v/v) FBS and 30 mg/mL Gentamycin
(Life Technologies, USA) at 37uC with 5% CO2 in a humidified
atmosphere.
Peripheral blood mononuclear cell preparation
PBMCs were isolated by density gradient centrifugation from
buffy coats from naı¨ve donors obtained from the Australian Red
Cross Blood Service. The buffy coat layer was first overlaid
carefully onto 15 mL of Ficoll Paque Plus (GE Healthcare, USA)
and centrifuged at 400 G with the brake off at room temperature
for 20 min. The PBMC band was then removed and washed 3
times with RPMI1640 at 450 G for 10 min at room temperature.
After washing, PBMCs were mixed with freezing medium
comprised of RPMI 1640, 20% (v/v) FBS and 10% (v/v)
dimethylsulfoxide (DMSO), before the freezing of aliquots in
liquid nitrogen.
Co-culture conditions
Co-culture experiments that incorporated P. falciparum-infected
red blood cells (iRBC), peripheral blood mononuclear cells
(PBMCs) and human brain endothelial cells 5i (HBEC) were
performed in flat bottom microplates (Nunc, Denmark) under
normoxic conditions. HBEC were seeded at 26104 per well into a
0.1% (w/v) gelatin pre-coated microplate and left to achieve
confluence. The ratios of the respective cell types were chosen to
be 2:5:100 for HBEC: PBMC: iRBC.[20] [82]. Different cell types
were added simultaneously. At the end of the 24 h incubation, the
co-culture experiment was terminated by centrifuging the plate at
room temperature, 300 G for 3 min. The supernatant was
removed for analysis of soluble products, while cells were subjected
to RNA isolation by magnetic beads, followed by reverse
transcription and real time PCR as described below.
RNA isolation, reverse transcription and real time PCR
RNA was extracted using the MagMAX 96 Blood RNA
isolation Kit (Life Technologies, USA) in accordance with the
manufacturer’s guidelines. Isolated RNA was primed with random
hexamers (GeneWorks, Australia) and reverse transcribed to
cDNA using BioscriptTM, (Bioline, UK). Real-time PCR analyses
were carried out using the Corbett Rotor-Gene 3000 (Qiagen,
Germany) in KAPA SYBRH FAST Universal 16strength qPCR
Master Mix (KapaBiosystems, USA) and 100 nmol/L of each
primer (see Table 1 for details). Thermal cycling conditions for the
real-time PCR were: 95uC for 2 min, followed by 45 cycles of
95uC for 15 sec and 60uC for 45 sec. The purity of the PCR
products was assessed by melting curve analysis and the expression
of the target genes was measured using a standard curve.
Cytometric bead array
IFN-c, IL-10, CXCL10 and TNF were measured using human
cytometric bead array flex sets (BD Biosciences, USA) according to
the manufacturer’s instructions, with the exception that all
sample/reagent volumes were decreased 5-fold. Samples were
run on an FC500 (Beckman Coulter, USA), and data were
analysed using FlowJo (Treestar, OR) and Prism (Graphpad, CA)
software. Limits of detection for the cytometric bead array are
3.7 pg/mL for IFN-c and 0.5 pg/mL for CXCL10, as stated in
the manufacturer’s instructions.
Interventions using neutralisation antibodies and
inhibitors
Neutralising antibodies for IFN-c (Clone 25718, R&D systems,
USA), MHCII (Clone TU36, Becton Dickinson, USA), ICOSL
(Clone 136726, R&D systems, USA) and IL-2 (Clone 5334, R&D
systems, USA), as well as Orencia (Bristol-Myers, Italy), were used
at 5 mg/mL, 10 mg/mL, 25 mg/mL, 5 mg/mL and 25 mg/mL
respectively to block IFNc bioactivity and/or expression. To
ensure that the effects seen with the neutralising antibodies and
fusion protein were specific, isotype-matched controls, IgG2A
(Clone 20102), IgG1 (Clone 11711), IgG2B (Clone 20116, R&D
systems, USA) and hIgG (IntragramH P, Australian Red Cross
Blood Service) were used. The antibodies were pre-incubated with
endothelial cells for 15 min before adding the PBMCs. After
incubating PBMCs and endothelial cells together with antibody
for another 30 min, iRBCs were added into the tripartite cultures
for the 24 h incubation period. YVAD (Cayman Chemical, USA),
also known as Z-YVAD-FMK (fluoromethylketone), is a caspase-1
inhibitor. Inclusion of YVAD at 50 mmol/L in the tripartite
cultures was similar to the neutralisation antibodies, with a vehicle
control of DMSO (0.135%, v/v) being included in the exper-
imental design.
Table 1. Primer sequences used.
Forward Reverse
IFN-c TGACCAGAGCATCCAAAAGA TTTCGCTTCCCTGTTTTAGC
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Transwell separations
Transwell inserts of pore size 0.4 mm (Corning, USA) were used
in concert with 24 well plates (Corning, USA). To optimise the
growth rate of the HBEC on this artificial support, the number of
cells seeded was 3.5 times more than that in a typical tripartite
culture in a 96 well plate. Samples were collected after 24 h of
culture, with mRNA being isolated from both the upper and lower
chambers when cells were present. Concurrently, supernatants
were sampled and kept at 280uC for further analysis.
NK cell depletion
PBMCs were sorted based on their surface marker staining.
Briefly, PBMCs were stained with anti-CD16 (clone 3G8,
Biolegend, USA), NKp46 (clone 9E2, BioLegend, USA) and
CD56 antibodies (clone MEM188, eBioscience, USA). NK cells
(CD16+, CD56+, NKp46+) were depleted using a FACSaria cell
sorter (Becton Dickinson, USA). NK-depleted PBMC were shown
to be .99% NK free before inclusion in tripartite cultures.
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